Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 18, 1999 |
| Grant date | May 28, 2002 |
| Priority date | — |
| Expiry date | Jun 18, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provide a method of treating sexual dysfunction in a female, including the vasculogenic symptoms of delayed vaginal engorgement, diminished vaginal lubrication, pain or discomfort with intercourse (dyspareunia), diminished vaginal sensation, diminished vaginal orgasm, diminished clitoral sensation or diminished clitoral orgasm, or of combating vaginal pain by stimulating peripheral pelvic nerve release of nitric oxide (NO). The method comprises administering to a female in need of such treatment a therapeutically effective amount of a compound which acts on a mid-brain pathway to increase blood flow to the ilio-hypogastric-pudendal artery bed and stimulate the release of nitric oxide (NO) from peripheral NANC nerve cells. The preferred compound for the method of this invention is apomorphine or one of its pharmaceutically acceptable salts, esters, or pro-drugs. Alternatively, the apomorphine is co-administered with an apomorphine-potentiating amount of an androgen, preferably testosterone either prior to, or concomitantly with, the administration of the apomorphine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.